Clinical Trials Browser

HER2-low Breast Cancer × eribulin × 90 days × Clear all

NCT06957886 2026-01-21

A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-low Recurrent/Metastatic Breast Cancer

Phase 3 Recruiting

HER2-low Breast Cancer